The Pharmaceutical Regulatory Affairs in China 2024 is a course dedicated to the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan.
The Pharmaceutical Regulatory Affairs in China 2024 covers topics such as:
- An overview of import and local manufacture registration
- Drug regulatory systems
- An interpretation of practical aspects
- Clinical product development including CMC regulatory requirements
- The opportunity to exchange experiences with other delegates
- Recent developments
The Pharmaceutical Regulatory Affairs in China 2024 brings together:
- Personnel from the following areas
- Clinical Development
- Analytical Research and Development
- New Business Development
- Quality Assurance
- Regulatory Authorities
- QScientists and Technical staff in
- Registration Departments
- Regulatory Affairs
- Medical Directors
The next Pharmaceutical Regulatory Affairs in China 2024 will be held on 29-30 Apr 2024.
